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Introduction
The number of people living with significant long-term con-
ditions is rising in an era of improved healthcare and an age-
ing population. It is estimated that the total number of people 
with at least one chronic condition will rise to 18 million in 
the United Kingdom by 2025.1 Recent data from Quality and 
Outcomes Framework Disease Register comparing 2006–
2007 to 2010–2011 data shows a 45% increase in chronic 
kidney disease (CKD) only second to cancers (79% change).2 
With long-term conditions forming 70% of the total health-
care budget in England and many patients wishing to gain 
better understanding and avoid admissions,3,4 new initiatives 
are being constantly explored. A recent report from a survey 
of 2500 people by the Institute of Public Policy research, a 
UK’s leading progressive think tank, found only 20% of peo-
ple had used assistive technologies to monitor their health 
and maintain independence.4 The use of telecare or telehealth 
medicine to support self-management has shown promising 
results, but most of the studies have been limited to chronic 
obstructive pulmonary disease (COPD), heart failure and 
diabetes. Data on the use of this technology in people with 
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other complex conditions such as end-stage renal disease 
(ESRD) are sparse.
NHS Ayrshire & Arran (A&A) provides peritoneal dialy-
sis (PD) services to the highest number of prevalent patients 
with ESRD on PD in Scotland (n = 37, 10% of total patients 
on renal replacement treatment at A&A, 31 December 
2014).5 The geography of the area dictates that people living 
in remote areas have to travel significant distances to access 
specialist medical care that is both expensive and time-con-
suming (up to 2.5 h one-way journey). For those requiring 
renal replacement therapy (RRT), PD allows the freedom to 
carry out treatment at home. In the event of illness or machine 
malfunction, the default position historically was for patients 
to attend the parent unit at the main hospital at the earliest 
opportunity. This necessarily resulted in time and cost impli-
cations for patients and staff alike.
We set up a pilot project using telehealth technology with 
the belief that it would help improve patient experience, pro-
mote self-management skills and allow early recognition and 
resolution of medical problems without the need for patients 
to attend the parent unit.
Methods
All adults >18 years of age with ESRD on PD were invited to 
participate. Subjects were recruited after receiving informa-
tion about the project following focus group meetings or dur-
ing routine clinic visits. There were no exclusion criteria 
apart from those not willing to participate.
Telemedicine system in PD patients
The application consisted of specialised software that was 
developed by the clinical team and uploaded into PODs. 
Each patient was given a POD, weighing scales and blood 
pressure machines that integrated with the software via 
Bluetooth technology. Patients were asked to record their 
vital data (weight, blood pressure, dialysis exchanges and 
ultrafiltration volumes) and answer a set of questions (wors-
ening swelling, shortness of breath, fever, abdominal pain, 
tenderness around PD catheter site and alarms from PD 
machine) on a regular basis. A twice-weekly questionnaire to 
assess dietary habits and medication intake patterns, and diet 
sheets along with web links formed part of the knowledge 
database in the PODs. Patients were able to access their own 
medical information via ‘Renal Patient View’ a nationally 
developed web portal. No data collection occurred during 
hospital admissions. Sample screens of the application are 
shown in Figure 1.
The application allowed remote monitoring of treatment 
regimes; early recognition of problems related to dialysis 
and promoted self-management skills. The PODs were not 
intended to be an emergency medical device and patients 
were advised to contact the medical team in the usual man-
ner for urgent or immediate medical attention.
Data transmission
Data were transmitted from the PODs with a roaming Subscriber 
Identity Module (SIM) card in an encrypted form. To ensure 
adequate reception, a site engineer installed PODs at patients’ 
residences. Patients were provided a 15- to 30-min one-to-one 
training and free phone number for technical issues. There were 
no associated costs to the patient apart from the ability to charge 
the device from power points. All devices were protected by 
passwords, and no patient identifiable information was stored 
within the devices. Clinicians were able to send non-urgent sin-
gle or group messages to patients via the PODs.
The clinical user interface
Alerts were regularly reviewed by the nursing team using a 
clinical user interface (CUI; a desktop application, later 
developed into a secure web portal) and followed up by a 
telephone call, home or clinic visit as deemed necessary. 
Vital data that fell outside individually predefined values 
were highlighted as red alerts. Alerts that needed dietetic or 
pharmacy input (amber alerts) were passed to colleagues via 
email or telephone calls. Patients were followed up directly 
by the relevant department. The CUI was installed at multi-
ple computers across renal services, and nurses, dieticians, 
pharmacists and doctors received training prior to its use. 
Data on all actions were recorded prospectively and reports 
generated for each event until the problem was resolved.
Outcomes measurement
Clinical interventions
Clinical specialist nurses, dieticians and pharmacists collected 
data on interventions, prospectively from alerts generated fol-
lowing patient review. These were categorised into avoidance 
of admission, support to self-manage, dietary advice, tele-
phone calls, home visits and clinic visits. Clinical interven-
tions were facilitated by examination of POD data related to 
blood pressure trends, weight gain, pedal oedema or worsen-
ing shortness of breath. Interventions to self-manage at home 
included the following: (1) recognition of fluid-related prob-
lems with ability to alter dialysis regimes or perform an extra 
manual exchange, (2) dietary advice on phone supported by 
supplementary written material on the PODs, (3) attainment of 
better understanding of ESRD/PD via web resources and (4) 
option to access personal electronic clinical records.
Kidney Disease Quality of Life-36TM and Quebec 
User Evaluation of Satisfaction with assistive 
Technology
Kidney Disease Quality of Life (KDQOL-36) English (UK), 
Version 1.26 and Quebec User Evaluation of Satisfaction 
with assistive Technology (QUEST) Version 27 were used to 
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assess quality of life (QOL) and user acceptability of tech-
nology, respectively. The KDQOL-36 is a self-reported 
patient survey that includes 36 items (items 1–12, the short 
form (SF)-12 as generic core; items 13–26, the burden of 
kidney disease; items 17–28, symptoms/problems and items 
29–36, effects of kidney disease). Measurements with higher 
scores indicate better QOL (range from 0 to 100).6
QUEST uses a scoring system based on a scale of 1–5 with 
1 indicating not satisfied at all and 5 being very satisfied. 
Twelve items, subdivided into three categories, were assessed. 
These include the assistive device (dimensions, ease in adjust-
ing, safety and security, durability, ease, comfort, effective-
ness), services (service delivery, repairs and servicing, 
professional services, follow-up services) and three most 
important items.7 Both these questionnaires were adminis-
tered at the start and end of the programme. Standard routine 
care remained unchanged until problems were flagged by the 
PODs’ system, at which point clinical interventions were at 
the discretion of the multi-disciplinary team.
Ethical reviews and permissions
Written permission was obtained from all patients prior to 
use of devices. A&A telehealth services obtained appropriate 
approvals from Information Technology Governance for 
secure data management. Institute for Matching Person and 
Technology provided permission for use of QUEST. The 
medical device (POD) was registered as a class I device 
(medical device software for telehealth loaded onto third part 
hardware) with Medicines and Healthcare products Agency 
Regulatory (MHRA) and ‘CE’ marked as per European leg-
islation. The project was not subject to ethical reviews as this 
was part of a quality improvement programme.
Results
Patient characteristics
A total of 22 patients (10 females and 12 males) on auto-
mated PD (APD), all self-caring and not on assisted PD, 
were identified at the start of the study. The average age was 
61.6 years at inception (range 26.4–93.4 years, median 
60.3 years). Primary renal diagnosis (PRD) was obtained 
from the European Renal Association–European Dialysis 
and Transplant Association (ERA-EDTA) coding system 
using the related web-based PRD search.8 They were grouped 
as diabetes, familial/hereditary nephropathies, glomerular 
disease, systemic disease, tubulointerstitial disease and 
Figure 1. Sample screens of the application.
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Table 2. Clinical interventions from generated alerts.
Interventions n
Admissions avoided 36
Medication change 4
Self-manage at home 154
Telephone calls to patients 258
Visits
 General practitioner 8
 Home 62
 Outpatient PD clinic 15
 PD day unit 7
Referrals/advice
 Dietician 16
 Pharmacy 2
n: number of patients; PD: peritoneal dialysis.
miscellaneous. The average RRT vintage was over 3 years 
(Table 1).
Data from the PODs
We received a total of 1195 alerts, 1074 red, directly affect-
ing clinical care, and 121 amber, related to diet and medica-
tion. The distribution of alerts by day of the week is illustrated 
in Figure 2. In all, 562 alerts (47% of total alerts) lead to an 
intervention while the remaining 53% required no further 
action. These alerts were generated mainly for safety rea-
sons, examples of which were single readings of abnormal 
weight or blood pressure. Further development in the soft-
ware will help minimise some of these extra alerts.
Clinical interventions
Data from interventions (Table 3) generated by alerts suggest 
that telehealth was effective in reducing admissions and sup-
porting patients to self-manage from the comfort of their 
home. The most frequent reason for admission avoidance was 
by early recognition of fluid overload. The data about admis-
sion avoidance were based on information collected from 
PODs and the expertise of the of the clinical nurse specialist. 
A standardised protocol was agreed where patients who 
demonstrated a persistent increase in weight (more than 1.5 kg 
over 72 h), had a persistent rise in blood pressure of >20 mmHg 
(systolic or diastolic) or reported symptoms of worsening 
shortness of breath or pedal oedema received a telephone call. 
A judgment for further review, intervention or admission was 
made using the above information in conjunction with the 
individual’s other medical co-morbidities (heart failure, sig-
nificant valvular disease or tendency to fluid overload).
QUEST and QOL outcomes
Table 2 illustrates the QUEST and QOL scores at the start 
and end of the programme. QUEST satisfaction scores 
remained high although there was no significant change in 
the QOL scores at the end of the programme. The three most 
important features about the PODs for patients were ease of 
use, effectiveness and safety.
Reasons for withdrawal
The two main reasons for withdrawal from the pilot project 
were the change in RRT modality (n = 4) and death (n = 2). 
The three earliest dropouts were at day 8 (renal transplanta-
tion), day 18 (death) and day 86 (dislike of technology). 
Other reasons for discontinuation are illustrated in Table 4. 
The retention rate excluding medical reasons was 91%.
Discussion
This is the first study in the United Kingdom that has utilised 
telehealth technology to promote self-management skills, 
assess user acceptability and collect data on admission 
avoidance in patients with ESRD on PD.
Previous reports from a Spanish group in stable patients 
undergoing treatment with PD demonstrated a reduction in the 
mean hospitalisation rate to 2.2 days/patient/year in the tele-
health support group (n = 25 patients) in comparison to 
5.7 days/patient/year in the control group (n = 32 patients). 
Table 1. Patient characteristics at recruitment.
Females, n (%) 10 (45)
Age in years, average (range) 61.6 (26.4–93.4)
Primary renal diagnosis, n (%)
 Diabetes 4 (18.2)
 Familial/hereditary 2 (9.1)
 Glomerular disease 5 (22.7)
 Miscellaneous 1 (4.5)
 Systemic 7 (31.8)
 Tubulointerstitial disease 3 (13.6)
PD vintage (months), mean (range) 32.7 (0–139.8)
RRT vintage (months), mean (range) 39.7 (0–194.5)
Days with PODs, mean (range) 341.9 (8.0–458.0)
PD: peritoneal dialysis; RRT: renal replacement therapy.
Figure 2. Alerts by day of the week.
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Time spent on teleconsultations was lower compared to hospi-
tal consultations (mean 22 versus 33 min, p < 0.01), and 89% 
(148 consultations) of the consultations lead to a medical 
intervention. In 96% cases (160 instances), patients felt tele-
medicine successfully replaced hospital visit. The study was 
conducted over a 2-year period in patients with a mean patient 
age of 48 ± 10 years.9 Our avoidance of admission data is simi-
lar. Interventions in our group occurred in 47% cases which is 
lower than the above report. This is possibly explained by the 
definition of intervention, as we did not record any interven-
tion that was not directly related to an alert.
A recent systematic review of 14 studies to analyse the 
outcomes of active therapies with telemedicine in patients 
with stroke, medical oncology and nephrology concluded 
that telehealth for rural patients was promising with the need 
for further robust data to study effectiveness, feasibility and 
safety.10 Of the three studies on telehealth in dialysis, two11,12 
were on HD patients. The third, on eight PD and three home 
HD patients, was a qualitative study of patient experiences 
and their views on how to optimise communication with 
health services and the role of telemedicine. Using semi-
structured interviews, the authors recorded experiences 
based on imagination of what telemedicine could add to their 
daily care of home dialysis. Although the potential of 
telemedicine was hypothetical, patients especially those with 
machines felt telemedicine could create security and help 
choose a home-based treatment. There were further scopes 
to use this technology to improve communication and train-
ing. Some patients without machines (continuous ambula-
tory PD), however, did not see the added value.13
An earlier study of a telemedicine system for PD patients 
consisted of data collection from an APD machine, blood pres-
sure monitor, weighing scale and an interview system via a digi-
tal camera and television. Data were collected on seven patients, 
one >90 years for 1–6 months (mean 3 months). The authors ten-
tatively concluded that patients benefited from telemedicine and 
this improved QOL.14 This technology has since been further 
developed in PD patients and integrated with cellular telephone 
devices enabling data collection on a wide variety of parameters 
including exercise level and blood glucose monitoring.15
Our self-reported QUEST questionnaires demonstrate a 
positive experience of the use of telehealth technology, but 
this does not translate into overall improvement in QOL. 
Issues surrounding QOL are complex and often need to be 
addressed by more than a single intervention. This is beyond 
the remit of this study and needs further exploration.
The largest study evaluating cost-effectiveness of tele-
health technology in the United Kingdom in patients with 
long-term conditions is the Whole System Demonstrator 
(WSD) trial. In this cluster randomised controlled study, 
1573 participants with heart failure, COPD or diabetes were 
followed up for 12 months. The cost for the telehealth group 
was higher and the quality-adjusted life-years (QALYs) 
gained were similar to those receiving standard care. The 
results were calculated on self-reported questionnaires of 
service use and did not include surrogate clinical markers 
known to affect morbidity.1 This is in contrast to the 3-year 
study in high-risk dialysis patients in the United States with 
nurse oversight that showed cost savings by avoidance of 
hospitalisations and emergency room visits.16 Although we 
did not collect data on costs, the avoidance of 36 admissions 
supports the potential for significant savings. The differ-
ences in health set-ups across the continents, the study of 
Table 3. QUEST and QOL scores at the start and end of programme.
Initial Final p-Values
QUEST,a mean (SD)
 Device 4.5 (0.5) 4.5 (0.6)  
 Service 4.2 (0.9) 4.1 (1.0)  
 Total (device + service) 4.4 (0.5) 4.3 (0.6)  
QOL, mean (SD)b
 Symptom/problem list 70.2 (17.0) 64.7 (15.8) 0.27
 Effects of kidney disease 75.6 (21.5) 69.6 (24.3) 0.37
 Burden of kidney disease 55.1 (33.9) 40.9 (24.7) 0.49
 SF-12 Physical Health Composite 29.7 (6.1) 31.5 (8.8) 0.54
 SF-12 Mental Health Composite 46.2 (10.4) 43.6 (11.6) 0.43
QUEST: Quebec User Evaluation of Satisfaction with assistive Technology; SD: standard deviation; QOL: quality of life; SF-12: short form-12.
aScores on a scale of 1–5 with 1 indicating not satisfied at all and 5 being very satisfied.
bScores on a scale of 0–100 with higher scores indicating better quality of life.
Table 4. Reasons for withdrawal from pilot project.
Reasons for withdrawal Patients (n) %
Medical reasons
 Renal transplant 3 13.6
 Change to HD 1 4.5
 Move to residential home 1 4.5
 Died 2 9.1
Others
 Lost POD 1 4.5
 Patient request 1 4.5
Total 9 40.9
HD: haemodialysis.
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different conditions and the methodologies in data collection 
may explain some of the differences seen.
Limitations
Our study is limited by the small patient numbers, absence of 
a control arm and being unblinded. The small and decreasing 
number of patients on PD in the developed world, however, 
makes it difficult to perform a sufficiently powered study to 
detect a significant difference. It is possible that patients would 
have sought medical help through other means in the absence 
of telehealth technology, but it is likely to have taken longer.
Despite these limitations, we believe our data are robust. 
Admissions were prevented following assessment by nurse 
specialist on agreed standardised protocols (as previously 
described). Furthermore, some participants who required 
intensive monitoring were managed within the community 
supporting the prevented admission data further. The instan-
taneous nature of the alerts received by the clinical team 
adds to the strength of the telehealth approach.
Patients were not able to communicate with clinicians via 
PODs and did not receive notifications that alerts had been 
reviewed. The ability to hold such a two-way communica-
tion would be a valuable development.
Conclusion
Telehealth is useful to monitor patients with ESRD on PD. It 
is acceptable across a wide age range and provides an addi-
tional resource for patients to self-manage their condition. 
Satisfaction scores and retention rates suggest a high level of 
acceptability. Further avenues in developing such technolo-
gies should be explored in renal patients.
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